NewsRx

Search our medical news database

Diagnostic Assays

FONAR Chairman and President Dr. Raymond Damadian Purchases Company Stock in Open Market

Published in Hospital Law Weekly, May 31st, 2007

FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM), announced that its Chairman, President and Founder, Raymond Damadian, M.D., purchased 8,500 shares of FONAR stock in the open market on May 15, 2007. This brings his ownership to 120,302.12 shares of common stock. Dr. Damadian has not sold a share of FONAR stock in more than a decade. The purchase was made pursuant to the Company's corporate governance guidelines for insider stock purchases.

In explaining his purchase, Dr. Damadian said, "It is my view that right now is the most exciting period in FONAR's 28-year history. FONAR Corporation has the 'electric lights' while all other MRI vendors remain with...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook